Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02536040 · ClinicalTrials.gov registry record · Phase 3
Stopping Cavities Study: Diammine Silver Fluoride
A Phase 3 study, sponsored by Advantage Dental Services.
- Completed
- Registry status
- Phase 3
- Development phase
- 66
- Enrollment target
NCT02536040 is a Phase 3 study that has completed, run by Advantage Dental Services. The registered enrollment target is 66 participants.
The verdict
NCT02536040, a Phase 3 study, has completed, sponsored by Advantage Dental Services.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 66 participants
- Enrollment target
Study Summary
This study is being conducted to test whether the use of diammine silver fluoride (also called silver diamine fluoride) hardens the cavity sufficiently so that it arrests.
Interventions
- OTHER Water
- DRUG 38% diammine silver fluoride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2016-01 |
| Est. Completion | 2016-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02536040
The ClinicalTrials.gov registry entry for NCT02536040 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Advantage Dental Services, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Water is the first listed.
NCT02536040 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02536040 about?
NCT02536040 is a clinical study titled "Stopping Cavities Study: Diammine Silver Fluoride". This study is being conducted to test whether the use of diammine silver fluoride (also called silver diamine fluoride) hardens the cavity sufficiently so that it arrests.
What is the current status of trial NCT02536040?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 66 participants. The study started on 2016-01. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02536040?
The interventions under investigation include: Water (OTHER), 38% diammine silver fluoride (DRUG).
Who is sponsoring clinical trial NCT02536040?
This trial is sponsored by Advantage Dental Services, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.